BEAT

HeartBeam, Inc.
$0.41previous close on: 9/11/2026

Company Information

Company Name
HeartBeam, Inc.
CIK
CIK0001779372
Category
<br>Emerging growth company
Ticker: Exchange
BEAT: Nasdaq, BEATW: Nasdaq
Fiscal Year End
December 31
Owner Organization
08 Industrial Applications and Services
SIC
3841
SIC Description
Surgical & Medical Instruments & Apparatus
Ticker
BEAT

SEC filing data through

Insider Sentiment

Last purchase
2026-04-16
Last sale
2025-12-18
Shares purchased (TTM)
1,126,250
Shares sold (TTM)
283,185
Buy ratio (TTM)79.9%

Institutional Sentiment

As of
2026-03-31
Institutional shares owned
5,144,200
Shares outstanding
40,588,385
Ownership
12.67%
+2.67% Y/Y

Earnings Market Reaction

Filing date
2026-08-13
Price on filing date
1-month reaction
-27.63%
3-month reaction
Pending
Drift continued6/11 (55%)
Faded / reversed5/11 (45%)

Balance Sheet

Values in millions ($)
Line item2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-30Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only columnTrend
Assets Current
Cash And Cash Equivalents At Carrying Value924234269131619
Debt Securities Held To Maturity Excluding Accrued Interest After Allowance For Credit Loss Current----24------
Prepaid Expense And Other Assets Current000000001110
Inventory Net000---0-----
Assets Current9252593610131719
Property Plant And Equipment Net211110000000
Other Assets Noncurrent000000000000
Assets11463693710141720
Accounts Payable And Accrued Liabilities Current-------21111
Liabilities Current
Accounts Payable Current1111111---1-
Accrued Liabilities Current2321111---1-
Liabilities Current23-222-21---
Liabilities233222221111
Stockholders Equity
Preferred Stock Value0000-0000000
Common Stock Value000000000000
Additional Paid In Capital958380727169585655545352
Retained Earnings Accumulated Deficit-87-82-77-72-67-62-56-51-46-41-37-33
Stockholders Equity813048259131619
Liabilities And Stockholders Equity11463693710141720
Related Party0000-00000000
Preferred Stock Par Or Stated Value Per Share0.000.000.000.000.000.000.000.000.000.000.000.00
Preferred Stock Shares Authorized101010101010101010101010
Preferred Stock Shares Outstanding000000000000
Common Stock Par Or Stated Value Per Share0.000.000.000.000.000.000.000.000.000.000.000.00
Common Stock Shares Authorized100100100100100100100100100100100100
Common Stock Shares Issued564140343434402727262726
Shares Outstanding564127343434272727262626

Select a line item above to chart it.

Recent filings

Financial statements beyond 3 years are for subscribers only.

Unlock 17+ years of income statements, balance sheets, and cash flow statements

Start 7-day free trial

HeartBeam, Inc. (BEAT) — SEC Financial Statements & Analysis

HeartBeam, Inc. (BEAT) is a surgical & medical instruments & apparatus company, incorporated in DE. HeartBeam, Inc. trades on Nasdaq as: BEAT, BEATW. HeartBeam, Inc. (BEAT)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-13. Based on that filing, HeartBeam, Inc. carries a market cap of $39.58M, a P/E ratio of -1.95x, a P/B ratio of 4.84x, an enterprise value of $30.80M, and an EV/EBITDA multiple of -1.52x. On profitability, it posts a Return on Equity (ROE) of -328.44%, a Return on Assets (ROA) of -244.27%, and a Return on Invested Capital (ROIC) of -11293.41%. Per share, it reports EPS of $-0.38, diluted EPS of $-0.38, free cash flow per share of $-0.27, and a dividend per share of $0.00. Over the trailing year, it posted net income growth of -0.24% year-over-year and EPS growth of -36.04% year-over-year. On the balance sheet, it maintains a current ratio of 3.66x, a quick ratio of 3.55x, working capital of $6.54M, a debt-to-equity ratio of 0.30x, a debt ratio of 0.23, an interest coverage ratio of -188.94x, free cash flow of $-14.01M (TTM), and net debt of $-8.78M. Figures sourced from SEC EDGAR.

Market Cap
$39.58M
P/E TTM
-1.95x
EPS TTM
$-0.38
P/B TTM
4.84x
ROE TTM
-328.44%
ROA TTM
-244.27%
Debt To Equity
0.30x
Free Cash Flow TTM
$-14.01M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is HeartBeam, Inc. in?

HeartBeam, Inc. (BEAT) operates in the Surgical & Medical Instruments & Apparatus industry.

What exchange does BEAT trade on?

HeartBeam, Inc. (BEAT) trades on the Nasdaq.

Where is HeartBeam, Inc. incorporated?

HeartBeam, Inc. is incorporated in DE.

When was HeartBeam, Inc. (BEAT)'s most recent SEC filing?

HeartBeam, Inc. (BEAT)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-13.

What is BEAT's market cap?

HeartBeam, Inc. (BEAT) has a market capitalization of $39.58M as of 2026-06-30.

What is BEAT's EPS (earnings per share)?

HeartBeam, Inc. (BEAT)'s trailing twelve month EPS is $-0.38 as of 2026-06-30.

What is BEAT's ROE (return on equity)?

HeartBeam, Inc. (BEAT)'s trailing twelve month Return on Equity (ROE) is -328.44% as of 2026-06-30.

What is BEAT's ROA (return on assets)?

HeartBeam, Inc. (BEAT)'s trailing twelve month Return on Assets (ROA) is -244.27% as of 2026-06-30.

What is BEAT's ROIC (return on invested capital)?

HeartBeam, Inc. (BEAT)'s trailing twelve month Return on Invested Capital (ROIC) is -11293.41% as of 2025-06-30.

What is BEAT's EV/EBITDA?

HeartBeam, Inc. (BEAT)'s trailing twelve month EV/EBITDA is -1.52x as of 2026-06-30.

Wall Street's data.
Main Street's price.